$239.10▴ 1.11%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
VanEck Biotech ETF's earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days2 articles
1 bullish1 neutral0 bearish
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
Should You Invest in the VanEck Biotech ETF (BBH)?
Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals?
Which Biotech ETF Is a Better Buy: Concentrated Bet or Broad Basket?
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?